Critical Pressure Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Liquidation

Critical Pressure General Information

Description

Developer of virtual drugs designed to treat vascular dysfunction and shock. The company's drugs have the potential to change clinical practice without the harmful effects of excess fluid administration and toxicities associated with the currently available catecholamine-based vasoactive agents, enabling clients to get supportive therapy during the critical period of hemodynamic compromise.

Contact Information

Website
www.critical-pressure.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Care of The Cambridge Partnership
  • Babraham Research Campus Babraham
  • Cambridge CB22 3AT
  • England, United Kingdom
+44 01223
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • Care of The Cambridge Partnership
  • Babraham Research Campus Babraham
  • Cambridge CB22 3AT
  • England, United Kingdom
+44 01223

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Critical Pressure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Bankruptcy: Liquidation 19-May-2025 Completed Bankruptcy: Liquidation
1. Early Stage VC (Series A) 15-Nov-2017 Completed Generating Revenue
To view Critical Pressure’s complete valuation and funding history, request access »

Critical Pressure Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Critical Pressure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202216888-D0 Composition Inactive 11-Nov-2022
GB-202116333-D0 Composition Inactive 12-Nov-2021
GB-202017925-D0 Composition Inactive 13-Nov-2020
GB-201719763-D0 Composition Inactive 28-Nov-2017
CA-2587444-A1 Guanidine derivatives as inhibitors of ddah Active 12-Nov-2004 C07C279/14
To view Critical Pressure’s complete patent history, request access »

Critical Pressure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Critical Pressure FAQs

  • When was Critical Pressure founded?

    Critical Pressure was founded in 2017.

  • Where is Critical Pressure headquartered?

    Critical Pressure is headquartered in Cambridge, United Kingdom.

  • What is the size of Critical Pressure?

    Critical Pressure has 1 total employees.

  • What industry is Critical Pressure in?

    Critical Pressure’s primary industry is Drug Discovery.

  • Is Critical Pressure a private or public company?

    Critical Pressure is a Private company.

  • What is Critical Pressure’s current revenue?

    The current revenue for Critical Pressure is .

  • How much funding has Critical Pressure raised over time?

    Critical Pressure has raised $13.2M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process